UI Hospitals and Clinics
Efficacy and safety of liraglutide in combination with metformin versus metformin monotherapy on glycemic control in children and adolescents with type 2 diabetes. A 26-week double-blind, randomized, parallel group, placebo controlled multi-center trial followed by a 26-week open-label extension
UIHC Department of Pediatrics/Division of Endocrinology are inviting children between the age of 10-17 years who have been diagnosed with type 2 diabetes to participate in a research study testing an investigational medicine called liraglutide. Call 1-866-309-0837 if interested. Compensation av
Sarah Salamati 1-866-309-0837 email@example.com
We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.